Background Despite the significant role that dyslipidemia is believed to play in the development of cardiovascular disease in diabetes, most studies examining diabetic dyslipidemia in the United States have not been population based, and very little data are available for African Americans with diabetes. We used data from a national survey to compare the effect of diabetes on lipid concentrations in African-American and white men and women. In addition, we examined other factors related to lipid concentrations and controlled for these factors in our analyses.
Background Despite the significant role that dyslipidemia is believed to play in the development of cardiovascular disease in diabetes, most studies examining diabetic dyslipidemia in the United States have not been population based, and very little data are available for African Americans with diabetes. We used data from a national survey to compare the effect of diabetes on lipid concentrations in African-American and white men and women. In addition, we examined other factors related to lipid concentrations and controlled for these factors in our analyses.
Methods and Resuks The Second National Health and Nutrition Examination Survey included a representative sample of 4177 African Americans and whites in the US civilian noninstitutionalized population 20 to 74 years old. These persons were classified as having non-insulin-dependent diabetes mellitus (NIDDM) (n=720) or as being nondiabetic (n=3457) based on an oral glucose tolerance test and a medical history of diabetes. Subjects were given an interview and physical examination that included measurement of serum lipoproteins, body mass index, body fat distribution, dietary fat intake, alcohol consumption, frequency of smoking, and use of medications. By uivariate analysis, a worse profile of mean cholesterol, triglycerides, and high-density lipoprotein cholesterol levels was generally apparent in NIDDM than in nondiabetic subjects, regardless of race or sex; a similar pattern was found for the prevalence of abnormal concentrations of these lipids. Lipid profiles appeared to be worse in whites with NIDDM than in African Americans. For mean total and low-density lipoprotein cholesterol, concentrations tended to be worse in women with NIDDM than in men. When other factors significantly affecting lipid levels were adjusted by multivariate analysis, we found that in all race/sex groups, total cholesterol was higher in NIDDM than in nondiabetic subjects but differences were not significant (P=.54), triglyceride concentrations were significantly higher in NIDDM subjects (P<.0001), and high-density lipoprotein cholesterol concentrations were lower in NIDDM subjects (P=.003). An interaction of diabetes with race was found for low-density lipoprotein cholesterol (P=.0001), where concentrations were substantially lower in NIDDM than in nondiabetic subjects among African Americans (P<.01) but slightly higher in NIDDM subjects among whites (P=.33). For other lipids, no differential effect of NIDDM was found by race or sex.
Conclusions In African-American and white men and women in the United States, NIDDM is associated with a pattern of Lipid analyses were performed on zeolite-treated isopropanol extracts using a Technicon Auto-Analyzer II (AAII), which uses a Lieberman-Burchard reagent for cholesterol and a fluorimetric measurement of triglycerides. Assays were standardized using controls provided by the Clinical Chemistry Standardization Section, Centers for Disease Control and Prevention. HDL cholesterol was determined on a supernatant fraction obtained after treatment of the sera with heparin and manganese chloride. Low-density lipoprotein (LDL) cholesterol was estimated by the Friedewald formula (LDL cholesterol=total cholesterol-HDL cholesterol-triglycerides/5) for subjects whose triglyceride concentration was <400 mg/dL.22 Individuals with a medical history of diabetes were not asked to fast, and thus their fasting triglyceride and LDL cholesterol values could not be determined. For total cholesterol, 1.0% of values were imputed (based on sex, age, and, in women, hormone/birth control pill use) because they were unavailable for study subjects; results from our study were nearly identical whether imputed values were included or excluded. For triglycerides and HDL cholesterol, values were obtained for 99.3% and 83.7% of subjects, respectively. Analyses by Sempos et a123 did not show any detectable bias in national prevalence estimates due to loss of NHANES II sample data. Abnormal lipid concentrations were defined on the basis of guidelines of the National Cholesterol Education Program (NCEP). 24 In addition to the presence of NIDDM, variables considered potentially to affect lipid concentrations included age, sex, race, body mass index, body fat distribution assessed by subscapular-to-triceps skinfold ratio, total daily fat intake (as percent of calories) based on 24-hour recall, average alcohol intake in the previous 3 months (in number of drinks per week, with beer, wine, and liquor in equivalents of 1.5 oz of 86 proof liquor per drink), current smoking (in number of cigarettes smoked daily), current use of birth control pills, and use in the last week of hormones, diuretics, or steroids.
Statistical Analyses
To provide estimates that were representative of the US population, data were weighted by the inverse of the participation rate of study subjects according to age, sex, race, income, and geographic location. Standard errors of mean values and proportions were obtained by the Taylor Series linearization method using the computer program SESUDAAN, which was developed for complex survey designs25; these were used to construct 95% confidence intervals.
Linear regression analysis was used to assess the effects of the variables described above on mean total cholesterol, LDL cholesterol, HDL cholesterol, and fasting triglyceride levels.
To examine whether the variables were associated with a more unfavorable lipoprotein concentration in diabetic relative to nondiabetic subjects or whether diabetes had a worse effect on lipoprotein concentration in certain subgroups, we included all interactions of diabetes with these variables. Because lipid concentrations are affected by whether women are premenopausal or postmenopausal, we controlled for this effect by including the interaction of sex x age. Because hormones may affect lipids differently in women than in men, we included the interaction of sexx hormone use; hormones, however, were used almost exclusively in women (98.0%).
In preparation for linear regression analyses, correlation matrices of the predictive factors were examined for collinearity. 26 We performed multiple linear regression analysis using the SURREGR program for complex surveys. 27 Continuous variables were standardized to control rounding errors that may introduce imprecision in parameter and variance estimation. 26 Squared terms of continuous variables were included in all models to examine whether relations were nonlinear. All other variables were coded categorically. Because the distribution of fasting triglycerides was not normally distributed, values for this lipid were log-transformed for regression analyses26 and then back-transformed for presentation of results. (Figs 1 through 4) . Mean total cholesterol concentrations (Fig 1) appeared to be higher in NIDDM than in nondiabetic subjects among whites at all ages (in whom differences were more pronounced in younger than in older subjects) and among younger Americans and in diabetic women than in diabetic men of either race. Mean LDL cholesterol levels (Fig 2) appeared to be lower in African Americans with NIDDM than in nondiabetic subjects. In white women and in older white men, LDL cholesterol levels appeared to be higher in those with NIDDM. Mean LDL cholesterol levels tended to be higher in diabetic whites than in diabetic African Americans and in diabetic women than in diabetic men. Mean HDI, cholesterol levels (Fig 3) appeared to be lower in NIDDM than in nondiabetic subjects, except in the youngest men. Mean HDL cholesterol levels tended to be lower in diabetic whites than in diabetic African Americans and appeared to be higher in diabetic women than in diabetic men, except in the youngest age group. Mean fasting triglyceride concentrations (Fig 4) appeared to be higher in diabetic than in nondiabetic subjects, especially in whites.
The prevalence of abnormal lipid concentrations by race, sex, and diabetes status in persons 40 to 69 years old is shown in Fig 5. The prevalence of total cholesterol of >240 mg/dL tended to be higher in diabetic than in nondiabetic subjects, except in African-American men; prevalence was particularly high (46% to 49%) in white X = = --- diabetic subjects. Prevalence of LDL cholesterol of > 160 mg/dL appeared to be higher in NIDDM than in nondiabetic subjects among white women but lower in NIDDM subjects among African Americans; prevalence was highest in white diabetic subjects of either sex. The prevalence of HDL cholesterol of <35 mg/dL tended to be higher in diabetic than in nondiabetic subjects in all race/sex groups. The prevalence of fasting triglycerides of >250 mg/dL appeared to be higher in NIDDM than in nondiabetic subjects, and rates were highest in white diabetic subjects of either sex.
Characteristics That Influence Serum Lipids, by Diabetes Status The Table shows the prevalence of characteristics that may affect lipid concentrations. Compared with nondiabetic subjects, NIDDM subjects were older and a higher proportion were women. A higher proportion of diabetic subjects were African American. NIDDM subjects had higher body mass index (particularly in women) and a more central body fat distribution than nondiabetic subjects. Alcohol use and smoking were less frequent in NIDDM than in nondiabetic subjects. Birth control pills were used less frequently in diabetic than in Model adjusts for the significant effects of age, body mass index, alcohol intake, smoking, diuretic use, and hormone use and is specified at mean levels of these significant factors. Non-insulindependent diabetes mellitus (NIDDM) category includes diagnosed and undiagnosed diabetes. 4 The association between triglycerides and coronary heart disease should be examined in African Americans. On the other hand, there appears to be racial differences in the influence of diabetes on LDL cholesterol; in whites with diabetes there tended to be higher levels of LDL, whereas in African Americans with diabetes there were lower levels. As discussed above, the metabolic consequences of diabetes on LDL metabolism may depend on the extent to which both the production and catabolic processes are influenced. Race may be one of the determinants that influences this balance. Although there are no specific studies of LDL cholesterol composition in African Americans with diabetes, it is likely that the compositional changes in LDL cholesterol believed to be atherogenic, such as glycation, susceptibility to oxidation, and the presence of small dense particles, are probably present in African Americans as well. Thus, it is still important to treat elevated LDL cholesterol concentrations when they are observed in African-American patients with NIDDM.
Of interest is that the associations of diabetes with elevated LDL and total cholesterol levels in univariate analyses appeared to be greater in women, especially among whites. A number of longitudinal populationbased studies have examined the relative magnitude of the increased risk conferred by diabetes on atherosclerosis in men compared with women. In several of the studies, women with diabetes were shown to have a greater increase in cardiovascular disease risk than men. [45] [46] [47] The observation of a potentially greater effect of diabetes on LDL cholesterol is a possible partial explanation for this difference.
In summary, results from the NHANES II have shown that in both whites and African Americans in the United States, NIDDM is associated with a pattern of dyslipidemia, including lower HDL cholesterol, higher triglycerides, and in whites somewhat higher LDL cholesterol, which can potentiate the atherosclerotic process. Atherosclerotic heart disease is the leading cause of death among individuals with diabetes, and a recent clinical trial has suggested that treatment of dyslipidemia may reduce coronary heart disease in individuals with diabetes.48 It is thus important that, in addition to the control of glucose, dyslipidemia be treated aggressively in an attempt to reduce risk for cardiovascular disease.
